Results 181 to 190 of about 77,701 (209)

Angiotensin II type 1 receptor blocker inhibits pulmonary injury.

Clinical and investigative medicine. Medecine clinique et experimentale, 2005
Pulmonary damage and fibrosis may be the result of diverse forms of injury and there is an association between pulmonary diseases and cardiovascular events. The purpose of this study was to evaluate the effects of an angiotensin II type 1 receptor blocker, valsartan, on systemic, cellular, and fibrotic consequences of pulmonary injury induced by the ...
G B John, Mancini, Nasreen, Khalil
openaire   +1 more source

Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers

Acta Diabetologica, 2005
Vascular protection is key to reducing the morbidity associated with diabetes. Angiotensin II is known to exert a variety of deleterious effects on the vasculature, and this is likely to be a major explanation of the protective benefits observed with blockade of the renin-angiotensin-aldosterone system (RAAS).
U, Kintscher, T, Unger
openaire   +2 more sources

Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.

International journal of clinical pharmacology research, 2005
There is a growing body of evidence that the renin-angiotensin system (RAS) plays a pivotal role in the pathogenesis of cardiovascular diseases. Indeed, large clinical trials have demonstrated a substantial benefit of the blockade of this system for cardiovascular-organ protection. Although several types of angiotensin II type 1 (AT1) receptor blockers
H, Kakuta, K, Sudoh, M, Sasamata, S, Yamagishi   +3 more
openaire   +1 more source

Ultrastructure and mechanical property of angiotensin II-stimulated tubular cells pretreated with angiotensin II type 1 receptor blocker

2011 IEEE Nanotechnology Materials and Devices Conference, 2011
Atomic force microscopy (AFM) has become an important device to visualize various cells and biological materials for non-invasive imaging. The major advantage of AFM compared to the conventional optical and electron microscopes is its convenience. Sample preparation for AFM does not need special coating or vacuum as a procedure.
Gi-Ja Lee, null Ji-Hye Kim, null Sung-Wook Kang, null Su-Jin Chae, Kyung-Hwan Jeong, Hun-Kuk Park   +5 more
openaire   +1 more source

[Current topic of next generation of angiotensin II type 1 receptor blockers].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Angiotensin receptor blockers(ARBs) are used as the first-choice anti-hypertensives for prevention of multiple organ damage. Recently, the next-generation ARBs have been expected to have more preventive effect for cardiovascular diseases. For example, metabosartans which have a partial agonistic effect of peroxisome proliferator-activated receptor ...
Masaki, Mogi, Masatsugu, Horiuchi
openaire   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

The antineoplastic effects of angiotensin II type 1 receptor blockers

Journal of Hypertension, 2013
openaire   +2 more sources

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

Lancet, The, 2021
Julio Rosenstock, Juan Frias, Shizuka Kaneko   +2 more
exaly